Becker's Spine Review

Beckers-July-2023-spine-review

Issue link: https://beckershealthcare.uberflip.com/i/1503164

Contents of this Issue

Navigation

Page 19 of 23

20 20 HEALTHCARE NEWS CVS, Amazon shutting down their health businesses By Naomi Diaz A mazon and CVS have been trying their hand at the healthcare industry for years, but not without fail — the two healthcare disruptors recently announced that they would be shuttering some of their healthcare initiatives. Here are three initiatives being shuttered, as reported by Becker's since August 25: 1. CVS Health told Becker's it was wrapping up its clinical trials unit that launched two years ago to focus on its core business and "long-term strategic priorities." The company aims to wind down the clinical trials unit in phases, with a full exit expected by Dec. 31, 2024. 2. On April 26, Amazon said it will be shutting down Halo, its health and fitness device line, starting July 31. Come Aug. 1, all Amazon Halo devices and the Amazon Halo app will no longer function, according to the company. 3. Amazon decided to cease operations of Amazon Care on Dec. 31, 2022. Neil Lindsay, senior vice president of Amazon Health Services, said this was due to service not living up to its expectations for its enterprise customers, which included Whole Foods, Hilton, Silicon Labs and Precor. n 11 highest paid CEOs in healthcare By Molly Gamble P harmaceutical and health insurance CEOs were among the highest-paid executives of the largest U.S. companies in 2022, according to Equilar. Each year, Equilar ranks the 100 top-paid CEOs of America's largest companies by revenue based on the proxy statements they file by March 31. Many of the companies in the Equilar 100 are consistent year to year, although the list is not the same each year due to changes in revenue and floating filing dates. Overall, median CEO pay reached $22.3 million in 2022 — a 7.7 percent increase among the same companies from 2021. All pay components increased except for cash bonuses, the median value of which decreased by 5.9 percent. e CEO-to-worker pay ratio reached 288:1 on the Equilar 100 compared to the ratio of 254:1 one year prior. e highest-paid executive on the Equilar 100 is Barry McCarthy, president and CEO of Peloton, who was awarded over $168 million in 2022. Here are the 11 healthcare CEOs who made the list, listed with their total compensation for 2022 and their placement on the Equilar 100. Albert Bourla, PhD Chairman and CEO, Pfizer Total compensation: $30,543,706 Rank on Equilar 100: 20 Richard Gonzalez Chairman and CEO, AbbVie Total compensation: $25,847,971 Rank on Equilar 100: 33 Joseph Zubretsky President and CEO, Molina Healthcare Total compensation: $22,131,256 Rank on Equilar 100: 52 Daniel O'Day Chairman and CEO, Gilead Sciences Total compensation: $21,621,253 Rank on Equilar 100: 58 Robert Ford Chairman and CEO, Abbott Laboratories Total compensation: $21,452,566 Rank on Equilar 100: 60 David Ricks Chairman and CEO, Eli Lilly Total compensation: $21,398,135 Rank on Equilar 100: 61 David Cordani Chairman, president and CEO, e Cigna Group Total compensation: $20,965,504 Rank on Equilar 100: 66 Gail Boudreaux President and CEO, Elevance Health Total compensation: $20,931,081 Rank on Equilar 100: 67 Giovanni Caforio Chairman and CEO, Bristol-Myers Squibb Co. Total compensation: $20,053,032 Rank on Equilar 100: 77 Stéphane Bancel CEO, Moderna Total compensation: $19,363,648 Rank on Equilar 100: 84 Kevin Lobo Chair and CEO, Stryker Total compensation: $18,563,214 Rank on Equilar 100: 95 n

Articles in this issue

view archives of Becker's Spine Review - Beckers-July-2023-spine-review